Follow Us

 

Fosamax Side Effects Lawsuit News Archive

Judge Denies Merck’s Motions During Second Fosamax Femur Fracture Lawsuit
- Ennis & Ennis
04/15/2013 - The judge in the second Fosamax femur fracture trial made several important rulings, which could have important implications in the outcome of the trial.  According to a Law 360 article published on April 11, 2013, Judge Joel Pisano rejected Merck’s attempt to block the testimony of eight doctors for the Plaintiff and rejected Merck’s argument that four of Plaintiff’s expert witness were not qualified to testify about the femur fractures being related to Fosamax.
READ MORE::

Second Fosamax Femur Fracture - Fosamax Broken Leg Lawsuit Trial Starts
- Ennis & Ennis
04/11/2013 - The second trial alleging that osteoporosis drug Fosamax caused a femur fracture/broken leg (thigh bone) began this week before U.S. District Judge Joel Pisano in Trenton, New Jersey. It is the second case against Merck, the manufacturer of Fosamax, in as many months after the first case ended in a mistrial due the illness of the Plaintiff during the middle of trial.
READ MORE::

First Fosamax Femur Fracture Lawsuit Trial Starts
- Ennis & Ennis
03/15/2013 - The nation’s first trial involving claims that Fosamax caused femur fractures began this week in New Jersey Superior Court, Atlantic County. According to the Plaintiff, Christina Su, Merck& Co. ignored signs that long-term use of drugs known as bisphosphonates, like Fosamax, caused femur bones to deteriorate.
READ MORE::

Plaintiff Wins Final Bellwether Fosamax Trial - Merck Hit With $285,000 Verdict For Osteonecrosis of the Jaw
- Ennis & Ennis
02/06/2013 - Merck & Co., the manufacturers of the popular osteoporosis drug Fosamax, suffered a defeat during the last bellwether trial in multidistrict litigation alleging that Fosamax causes jaw bone deterioration.  The New York federal jury determined that the pharmaceutical giant failed to warn of the risks associated with Fosamax and ordered Merck to pay the Plaintiff, Rhoda Scheinberg, $285,000 in damages for her failure-to-warn claim.
READ MORE::

Fosamax Lawsuits, New Studies and Generics Hammer Sales of Fosamax
- Ennis & Ennis
11/28/2012 - For years, Fosamax has been the golden goose for Merck consistently laying over $3.5 billion in sales per year.  However, Merck’s goose may be cooked due to multiple studies linking spontaneous femur fractures and osteonecrosis of the jaw in long-term use of the drug. Litigation arising out of these injuries and the availability of a generic form is driving the nail further into the coffin. Ongoing research continues to reinforce the links between Fosamax and bone damage.
READ MORE::

Fosamax Femur Fracture Lawsuits Climbing to 3,500 Filed Cases
- Ennis & Ennis
10/24/2012 - According to various court documents in New Jersey and California, there are now nearly 3,500 Fosamax femur fracture lawsuits filed in state and federal courts in New Jersey and California. As of October 19, 2012, there were 2,361 Fosamax cases filed in New Jersey state court, approximately 500 Fosamax cases filed in California and approximately 630 more Fosamax lawsuits filed in the federal MDL.
READ MORE::

Fosamax Litigation Update: Case Management Conference Scheduled for November 2012
- Ennis & Ennis
10/19/2012 - Fosamax femur fracture and Fosamax osteonecrosis of the jaw lawsuits filed in New Jersey Superior Court are scheduled for a Case Management Conference on November 9, 2012 before The Honorable Carol E. Higbee.
READ MORE::

Merck Settles Fosamax Jaw Decay Lawsuit while Femur Fracture Cases Continue to Mount
Ennis & Ennis, P.A. Provides a Fosamax Litigation Update
- Ennis & Ennis
09/27/2012 - After extensive litigation, Merck, the manufacturer of the osteoporosis drug, Fosamax has finally agreed to a confidential settlement agreement with Plaintiff Shirley Boles. Ms. Boles took Fosamax and suffered osteonecrosis of the jaw and was awarded $8 million in damages by a jury-which a judge reduced to $1.5 million. (Boles v. Merck & Co., Inc., 06 Civ. 9455 (JFK). Rather than accept the reduced award, Ms. Boles was preparing for another trial, however, Merck decided to settle confidentially rather than face another trial with potentially high damages.
READ MORE::

Study Confirms Link Between Atypical Femur Fractures and Boniva Use
- Ennis&Ennis
05/23/2012 - After the New England Journal of Medicine published their findings that use of biphosphonates is not deemed beneficial outside of a 3 to 5 year window, the Archives of Internal Medicine have confirmed that prolonged use of the drug increases risk for atypical fractures of the femur.
READ MORE::

Long Term Use of Bone-Strengthening Drugs Like Fosamax Could Lead to Weaker Bones and Side Effects
- Ennis & Ennis
05/11/2012 - According to an FDA review of biphosphonates published in the New England Journal of Medicine, long term use of these drugs, commonly known as Boniva or Fosamax, could lead to weakened bones. In these cases women suffered very serious Fosamax side effects including unusual femur fractures and osteonecrosis of the jawbones.
READ MORE::

FDA Advisory Panel To Review Safety of Popular Bone Drugs Fosamax, Boniva and Reclast
- Ennis&Ennis
09/08/2011 - Two FDA advisory panels convene on Friday to review the long-term safety of biophosphonates such as Fosamax and its generics, Boniva and Actonel. The advisory panels will discuss whether women who take biophosphonate bone drugs should take a “drug holiday” due to increased concerns of the long-term use side effects and they will also review the medical evidence to date to determine whether biophosphonates have proven to be safe and effective in use longer than three to five years.
READ MORE::

Fosamax Femur Fractures and Osteonecrosis of the Jaw to be Reviewed by FDA in September
- Ennislaw
07/19/2011 - On July 14, 2011 the FDA announced an FDA advisory committee will hold a meeting on September 9, 2011 at 8 AM to discuss the benefits and risks of long term bisphosphonate use for the treatment and prevention of osteoporosis. The drugs that will be reviewed will be Fosamax, Actonel, Boniva and Reclast. The law firm of Ennis & Ennis, P.A. notes this is a necessary step for informing the public of the potential dangers of bisphosphonates.
READ MORE::

Under no circumstances should you discontinue taking any medication, including Fosamax, without first consulting with your doctor.

If you or a loved one have suffered from Fosamax Side Effects such as Osteonecrosis of the Jaw (ONJ), Low Energy Femur Fractures, Esophageal Cancer, or other serious side effects you may be entitled to compensation. Contact the Fosamax Attorneys of Ennis & Ennis, P.A. today for a Free Nationwide Case Evaluation. Our experienced Fosamax Lawyers can answer any questions you may have about Fosamax side effects, and a potential Fosamax Lawsuit. Fill out our online case evaluation form on this page or contact us toll free at 1-800-856-6405.

Fosamax Side Effects Lawsuit